Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections

NCT05750589 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Retinal Disease

Interventions

DRUG: IRX-101
DRUG: Providone-Iodine

Sponsor

iRenix Medical, Inc.